Alabama Therapeutics CRS (5801) — Birmingham, Alabama

Alabama Therapeutics CRS (5801) is a clinical research site located in Birmingham, Alabama, United States 35294.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Alabama Therapeutics CRS (5801) has participated in 7 clinical trials.

Therapeutic areas: HIV Infections, HIV-1 Infection.

Sponsors: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alabama Therapeutics CRS (5801)?

Alabama Therapeutics CRS (5801) has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alabama Therapeutics CRS (5801) conducted?

Alabama Therapeutics CRS (5801) has 7 clinical trials on record. Their work covers HIV Infections, HIV-1 Infection.

Is Alabama Therapeutics CRS (5801) accredited by Crixeo Health?

Alabama Therapeutics CRS (5801) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Alabama Therapeutics CRS (5801)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.